Effective measurement of risperidone treatment outcome for persons with borderline personality disorder: the UAB Borderline Rating Scale (BRS).
Phase of Trial: Phase IV
Latest Information Update: 15 Mar 2012
At a glance
- Drugs Risperidone (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
- 15 Mar 2012 Actual end date (October 2007) added as reported by ClinicalTrials.gov.
- 15 Mar 2012 Additional lead trial investigator (Celia T. Huston) identified as reported by ClinicalTrials.gov.
- 15 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.